N-aryl or N-heteroaryl pyrazolidine and pyrazolidinone derivatives as prostaglandine receptor inhibitors

Details for Australian Patent Application No. 2007286135 (hide)

Owner Allergan, Inc.

Inventors Old, David W.; Dinh, Danny T.

Agent Davies Collison Cave

Pub. Number AU-A-2007286135

PCT Pub. Number WO2008/021933

Priority 60/821,994 10.08.06 US

Filing date 9 August 2007

Wipo publication date 21 February 2008

International Classifications

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61P 17/14 (2006.01) Drugs for dermatological disorders

A61P 27/06 (2006.01) Drugs for disorders of the senses

C07D 231/08 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 231/22 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

5 March 2009 PCT application entered the National Phase

  PCT publication WO2008/021933 Priority application(s): WO2008/021933

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007286136-Bayonet connection

2007286131-Leptin and growth hormone receptor gene markers associated with rearing, carcass traits and productive life in cattle